Those who are vaccinated will survive the alien invasion. Those who are not vaccinated will die slow, painful deaths once the aliens invade.

(http://www.autoadmit.com/thread.php?thread_id=4934884&forum_id=2/en-en/#43215255)

https://rumble.com/vn482j-dr.-carrie-madej-first-u.s.-lab-examines-vaccine-vials-horrific-findings-re.html?fbclid=IwAR0efr8xcwx6WFUzlsnYdLgaBg3u1Y2IRIIPl6Y4oOhKSy9HzCGl-ZvcXN8

(http://www.autoadmit.com/thread.php?thread_id=4934884&forum_id=2/en-en/#43215978)

Johnson & Johnson's one-shot COVID vaccine has been linked to another blood-clotting condition by EU regulators which they warn could be life-threatening.

The European Medicines Agency (EMA) said the new, possibly life-threatening clotting condition known as venous thromboembolism (VTE) will be included on the J&J product label was separate a previously-linked side effect known as thrombocytopenia syndrome (TTS).

VTE typically begins by a clot forming in a vein of a leg, arm or groin, which then travels to the lungs and blocks the blood supply there.

Regardless of any vaccine use, VTE is most commonly caused by injury or lack of movement in bedridden patients.

The EU watchdog said most clots had occurred in the brain and abdomen, as was the case with AstraZeneca's shot, Vaxzevria, which is also being studied for similar problems.

...

The two products are based on harmless vector viruses that instruct human cells to make a protein that primes the immune system against future coronavirus infections.

Some scientists say the similar design of the AstraZeneca and J&J shots may explain a possible link with clotting.

Both vaccines are based on a technology that uses a modified version of adenoviruses, which cause the common cold, as vectors to ferry instructions to human cells.

The similar side-effects suggest the inactivated adenovirus may be causing the problems, said Jonathan Ball, professor of molecular virology at Britain's University of Nottingham.

'It's important to remember though, that in most people the benefits of these vaccines far outweigh the risks - these are incredibly rare potential side-effects,' he said.

J&J, which recorded $100 million in COVID-19 vaccine sales, announced on Tuesday that it would resume its roll-out to Europe although vaccine bottles would carry a warning for a potential risk for rare blood clots.

(http://www.autoadmit.com/thread.php?thread_id=4934884&forum_id=2/en-en/#43218162)